ABCC7 p.Tyr122His
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 16973827
[PubMed]
Radpour R et al: "Two novel missense and one novel nonsense CFTR mutations in Iranian males with congenital bilateral absence of the vas deferens."
No.
Sentence
Comment
10
This approach allowed us to detect one novel nonsense mutation (K536X) in the nucleotide-binding domain 1 (NBD1) region and two novel missense mutations (Y122H and T338A) in the M2 and M6 regions of CFTR gene in our studied population, which were not reported previously.
X
ABCC7 p.Tyr122His 16973827:10:154
status: NEW14 Because Y122H and T338A mutations were compound heterozygote with the IVS8-5T, it is difficult to judge the severity of these mutations and their role in the CBAVD phenotype.
X
ABCC7 p.Tyr122His 16973827:14:8
status: NEW45 Mutation Location Mutation type Nucleotide alteration Allele frequency (%) K536X Exon 11 Nonsense 1738 A to T 1/224 (0.45) Y122H Exon 4 Missense 496 T to C 1/224 (0.45) T338A Exon 7 Missense 1144 A to G 1/224 (0.45) Figure 1.
X
ABCC7 p.Tyr122His 16973827:45:123
status: NEW47 (B) Trans-abdominal ultrasonography in Patient no. 100 with Y122H and IVS8-5T mutations.
X
ABCC7 p.Tyr122His 16973827:47:60
status: NEW68 The second mutation was a transition mutation of 496T→C in exon 4 (Figure 2) which causes amino acid change of tyrosine to histidine at position 122 of the CFTR polypeptide.
X
ABCC7 p.Tyr122His 16973827:68:118
status: NEW78 The numbering of the reported mutations is as follows: c.1738A>T or p.Lys536Stop (K536X), c.496T>C or p.Tyr122His (Y122H) and c.1144A>G or p.Thr338Ala (T338A).
X
ABCC7 p.Tyr122His 16973827:78:104
status: NEWX
ABCC7 p.Tyr122His 16973827:78:115
status: NEW96 Y122H A nucleotide substitution (transition) in exon 4 was compound heterozygote with IVS8-5T in a patient (Patient no. 100) who presented obstructive azoospermia with hypoplastic vas deferens diagnosed on clinical palpation.
X
ABCC7 p.Tyr122His 16973827:96:0
status: NEW98 Y122H is located in TMD-M2.
X
ABCC7 p.Tyr122His 16973827:98:0
status: NEW110 Mutation type IVS8-(TG)mTn M470V n (%) K536X (TG)10 9T / (TG)10 9T M/V 1 (0.89) Y122H (TG)11 7T / (TG)13 5T V/V 1 (0.89) T338A (TG)11 7T / (TG)13 5T M/V 1 (0.89) Figure 3.
X
ABCC7 p.Tyr122His 16973827:110:80
status: NEW121 Because Y122H and T338A mutations were compound heterozygote with the IVS8-5T, it is difficult to judge the severity of these mutations and their role in the CBAVD phenotype.
X
ABCC7 p.Tyr122His 16973827:121:8
status: NEW
PMID: 17314234
[PubMed]
Radpour R et al: "Molecular study of (TG)m(T)n polymorphisms in Iranian males with congenital bilateral absence of the vas deferens."
No.
Sentence
Comment
77
CFTR gene mutations in 112 CBAVD patients and 7 CBAVD patients* Samples Mutation genotype3 (TG)m(T)n n (%) CBAVD Two mutations detected (5 /112 5 4.46%) F508del / R117H (TG)10 9T / (TG)10 9T 1 (0.89) F508del / 621+1G.T (TG)11 7T / (TG)11 7T 1 (0.89) 1540A/G / 1540A/G (TG)11 7T / (TG)11 7T 2 (1.79) R347H / R117H (TG)10 9T / (TG)11 7T 1 (0.89) One mutation detected with one 5T allele (32 / 112 5 28.57%) G551D / - (TG)10 7T/ (TG)13 5T 2 (1.79) F508del / - (TG)12 7T/ (TG)13 5T 8 (7.14) (TG)11 9T/ (TG)13 5T 6 (5.36) 1717-1G.A / - (TG)11 7T/ (TG)12 5T 4 (3.57) R117H / - (TG)12 7T/ (TG)13 5T 2 (1.79) 621+1G.T / - (TG)11 7T/ (TG)13 5T 3 (2.68) 2 (1.79) 1540A/G / - (TG)11 7T/ (TG)13 5T 2 (1.79) R553X / - (TG)12 7T/ (TG)13 5T 1 (0.89) Y122H / -4 (TG)11 7T / (TG)13 5T 1 (0.89) T338A / -4 (TG)10 7T / (TG)13 5T 1 (0.89) No mutation detected with two 5T alleles (11 / 112 5 9.82%) - / - (TG)12 5T / (TG)13 5T 3 (2.68) - / - (TG)13 5T / (TG)13 5T 8 (7.14) One mutation detected without 5T allele (35 / 112 5 31.25%) G85E / - (TG)11 7T / (TG)11 7T 2 (1.79) G551D / - (TG)10 9T / (TG)12 7T1 1 (0.89) 621+1G.T / - (TG)11 7T / (TG)11 7T 2 (1.79) (TG)10 9T / (TG)11 7T 1 (0.89) R334W / - (TG)12 7T / (TG)10 7T 1 (0.89) F508del / - (TG)11 7T / (TG)11 7T 7 (6.25) (TG)11 9T / (TG)12 7T 3 (2.68) (TG)10 9T / (TG)10 9T 2 (1.79) 1717-1G.A / - (TG)11 7T / (TG)12 7T 3 (2.68) (TG)10 9T / (TG)11 7T 2 (1.79) R117H/- (TG)12 7T / (TG)12 7T 2 (1.79) (TG)10 9T / (TG)11 7T 1 (0.89) 2789+5G.A / - (TG)10 7T / (TG)11 7T 1 (0.89) 3120+1G.A / - (TG)10 9T / (TG)11 7T 2 (1.79) R560T / - (TG)10 9T / (TG)11 7T 1 (0.89) N1303K / - (TG)10 9T / (TG)11 7T 1 (0.89) 1651A/G / - (TG)11 7T / (TG)12 7T 1 (0.89) R553X / - (TG)10 9T / (TG)10 7T 1 (0.89) K536X / -4 (TG)10 9T / (TG)10 9T 1 (0.89) No mutation detected with one 5T alleles (7 / 112 5 6.25%) - / - (TG)13 5T / (TG)12 7T 3 (2.68) - / - (TG)13 5T / (TG)10 9T 4 (3.57) No mutation detected (22 / 112 5 19.64%) - / - (TG)11 7T / (TG)11 7T 12 (10.71) - / - (TG)11 7T / (TG)12 7T 1 (1.79) - / - (TG)10 9T / (TG)10 9T 3 (2.68) - / - (TG)10 9T / (TG)11 7T 6 (5.36) CUAVD One mutation detected without 5T allele (2 / 7 5 28.57%) R334W / - (TG)10 9T / (TG)11 7T 1 (14.29) R117H / - (TG)11 7T / (TG)11 7T 1 (14.29) No mutation detected with one 5T alleles (3 / 7 5 42.86%) - / - (TG)11 9T / (TG)13 5T 2 (28.57) - / - (TG)10 7T / (TG)13 5T 1 (14.29) No mutation detected (2 / 7 5 28.57%) - / - (TG)10 9T / (TG)12 7T 2 (28.57) * CBAVD indicates congenital bilateral absence of the vas deferens; CUAVD, congenital unilateral absence of the vas deferens.
X
ABCC7 p.Tyr122His 17314234:77:735
status: NEW